Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies.
Yves Fradet(Centre hospitalier universitaire de Québec), Lloyd J. Old(Gynecologic Oncology Group), Megan E. Daly(University of California Davis Medical Center), Willet F. Whitmore(Memorial Sloan Kettering Cancer Center), Carlos Cordon‐Cardo(Icahn School of Medicine at Mount Sinai), Timothy M. Thomson(Universidad Peruana Cayetano Heredia), M R Melamed(Memorial Sloan Kettering Cancer Center), Kenneth O. Lloyd(Memorial Sloan Kettering Cancer Center)
Cited by 273
Related Papers
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
Tumor-infiltrating NY-ESO-1–specific CD8 <sup>+</sup> T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
|Proceedings of the National Academy of Sciences|2010|844